Notably, ADA exhibited minimal cytotoxic effects on BM-MNCs from healthy donors, indicating selective therapeutic specificity toward MM cells without significant toxicity to normal cell counterparts (Figure 1D). This evidence concerns the gene ADA and Miyoshi myopathy.